Back to Search Start Over

Clinical characteristics and outcomes of patients with adult congenital heart disease listed for heart and heart‒lung transplantation in the Eurotransplant region.

Authors :
Becher PM
Schrage B
Weimann J
Smits J
Magnussen C
Reichenspurner H
Goßling A
Rodrigus I
Dumfarth J
de Pauw M
François K
van Caenegem O
Ancion A
Van Cleemput J
Milicic D
Moza A
Schenker P
Röhrich L
Schönrath F
Thul J
Steinmetz M
Schmack B
Ruhparwar A
Warnecke G
Rojas SV
Sandhaus T
Haneya A
Eifert S
Welp H
Ablonczy L
Wagner F
Westermann D
Bernhardt AM
Knappe D
Blankenberg S
Kirchhof P
Zengin E
Sinning C
Source :
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation [J Heart Lung Transplant] 2020 Nov; Vol. 39 (11), pp. 1238-1249. Date of Electronic Publication: 2020 Jul 25.
Publication Year :
2020

Abstract

Background: The therapeutic success in patients with congenital heart disease (CHD) leads to a growing number of adults with CHD (adult CHD [ACHD]) who develop end-stage heart failure. We aimed to determine patient characteristics and outcomes of ACHD listed for heart transplantation.<br />Methods: Using data from all the patients with ACHD in 20 transplant centers in the Eurotransplant region from 1999 to 2015, we analyzed patient characteristics, waiting list, and post-transplantation outcomes.<br />Results: A total of 204 patients with ACHD were listed during the study period. The median age was 38 years, and 62.3% of the patients were listed in high urgency (HU), and 37.7% of the patients were in transplantable (T)-listing status. A total of 23.5% of the patients died or were delisted owing to clinical worsening, and 75% of the patients underwent transplantation. Median waiting time for patients with HU-listing status was 4.18 months and with T-listing status 9.07 months. There was no difference in crude mortality or delisting between patients who were HU status listed and T status listed (p = 0.65). In multivariable regression analysis, markers for respiratory failure (mechanical ventilation, hazard ratio [HR]: 1.41, 95% CI: 1.11-1.81, p = 0.006) and arrhythmias (anti-arrhythmic medication, HR: 1.42, 95% CI: 1.01-2.01, p = 0.044) were associated with a higher risk of death or delisting. In the overall cohort, post-transplantation mortality was 26.8% after 1 year and 33.4% after 5 years.<br />Conclusions: Listed patients are at high risk of death without differences in the urgency of listing. Respiratory failure requiring invasive ventilation and possibly arrhythmias requiring anti-arrhythmic medication indicate worse outcomes on waiting list.<br /> (Copyright © 2020 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1557-3117
Volume :
39
Issue :
11
Database :
MEDLINE
Journal :
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Publication Type :
Academic Journal
Accession number :
32778365
Full Text :
https://doi.org/10.1016/j.healun.2020.07.012